The global fight between Eli Lilly and Novo Nordisk for dominance in the red-hot weight-loss drug market is shifting to India, one of the fastest-growing pharmaceutical frontiers. As rising obesity and diabetes rates collide with expanding middle-class incomes, the country is becoming a pivotal battleground for the two drugmakers.On Thursday,…
Chipmakers across Asia rallied on Thursday after Nvidia’s stock closed at a record high, once again positioning the US-based…
XRP spiked nearly 6% in a powerful late-session surge, establishing fresh technical support above the $2.20 mark for the…
Siemens Energy share price has had a remarkable turnaround in the past two years. ENR jumped to a high…
The National Stock Exchange of India (NSE), the nation’s largest exchange and the world’s most active derivatives exchange, has…
The market sentiment in Asian markets continues to remain upbeat as most of the benchmark indices traded in green…
If you’re confused about what’s going on with the economy right now, you’re not alone. On one hand, unemployment…
XRP is consolidating near key resistance levels, with analysts increasingly pointing to an imminent breakout that could push the…